ARYx Therapeutics Inc (ARYX)
OTHER OTC:ARYX
US Market
Holding ARYX?
Track your performance easily

ARYx Therapeutics (ARYX) Financial Statements

4 Followers

ARYx Therapeutics Financial Overview

ARYx Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ARYx Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue-$ 18.60K$ 107.85M$ 27.65M$ 34.38M
Gross Profit-$ 12.90K$ 24.29M$ 5.07M$ 34.26M
EBIT$ -1.11M$ -6.22M$ 10.45M$ 4.85M$ 30.75M
EBITDA$ -1.09M$ -6.19M$ 13.84M$ 9.60M$ 35.04M
Net Income Common Stockholders$ -1.05M$ -6.22M$ 8.66M$ 5.12M$ 30.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 14.56M$ 18.40M$ 7.81M$ 11.31M$ 41.00K
Total Assets$ 15.23M$ 19.19M$ 336.43M$ 123.37M$ 107.05M
Total Debt$ 0.00$ 0.00$ 108.07M$ 25.62M$ 36.64M
Net Debt$ -14.56M$ -18.40M$ 100.26M$ 14.30M$ 36.60M
Total Liabilities$ 407.54K$ 3.32M$ 336.43M$ 123.37M$ 107.05M
Stockholders Equity$ 14.82M$ 15.86M$ 139.70M$ 82.01M$ 53.73M
Cash Flow-
Free Cash Flow$ -3.84M$ -3.59M$ -103.90M$ 19.54M$ -21.99M
Operating Cash Flow$ -3.84M$ -3.59M$ 8.23M$ 4.51M$ -1.76M
Investing Cash Flow$ 5.04M$ -5.06M$ -113.82M$ -6.01M$ -20.44M
Financing Cash Flow--$ 110.21M$ 12.68M$ 19.37M
Currency in USD

ARYx Therapeutics Earnings and Revenue History

ARYx Therapeutics Debt to Assets

ARYx Therapeutics Cash Flow

ARYx Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis